NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 31 filers reported holding NRX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88 | -46.3% | 339 | 0.0% | 0.00% | – |
| Q2 2023 | $164 | – | 339 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 339 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 339 | -100.0% | 0.00% | – |
| Q3 2022 | $650,000 | +64900.0% | 878,961 | +44882.7% | 0.00% | – |
| Q2 2022 | $1,000 | -94.1% | 1,954 | -71.9% | 0.00% | – |
| Q1 2022 | $17,000 | -32.0% | 6,952 | +34.1% | 0.00% | – |
| Q4 2021 | $25,000 | +1150.0% | 5,184 | +2345.3% | 0.00% | – |
| Q3 2021 | $2,000 | – | 212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 699,731 | $338,320 | 0.28% |
| CVI Holdings, LLC | 483,569 | $233,806 | 0.25% |
| ARMISTICE CAPITAL, LLC | 5,636,000 | $2,725,006 | 0.04% |
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $30,601 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,700 | $77,698 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $14,133 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $8,848 | 0.00% |
| JANE STREET GROUP, LLC | 15,052 | $7,278 | 0.00% |
| UBS Group AG | 2,758 | $1,332 | 0.00% |
| NewEdge Advisors, LLC | 2,125 | $1,028 | 0.00% |